EUVIMEDEUVIMED entdecken
Crossref

In vitro modulation the Notch pathway by piperine: A therapeutic strategy for docetaxel‐resistant and non‐resistant prostate cancer

Rui-Tao Wang, Hao-En Liu, Hui-Yuan Sun

Chemical Biology & Drug Design · 2024

DOI: 10.1111/cbdd.14562 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Biology & Drug Design, 2024. Verfasst von Rui-Tao Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Wujin Hospital Affiliated with Jiangsu University, Changzhou, China. Hauptthemen laut MEDLINE: Polyunsaturated Alkamides, Benzodioxoles, Alkaloids, Piperidines. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Docetaxel (DTX) resistance poses a significant challenge in the treatment of prostate cancer (PCa), often leading to chemotherapy failure. This study investigates the ability of piperine, a compound derived from black pepper, to enhance the sensitivity of PCa cells to DTX and elucidates its underlying mechanism. We established a DTX‐resistant PCa cell line, DU145/DTX, to conduct our experiments. Through a series of assays, including MTT for cell viability, flow cytometry for apoptosis, Transwell for cell migration and invasion, and western blot for protein expression analysis, we assessed the effects of piperine on these cellular functions and on the Notch signaling pathway components. Our results demonstrated that we successfully established the DTX‐resistant PCa cell line DU145/DTX. Piperine effectively decreased the viability of both DU145 and its DTX‐resistant counterpart, DU145/DTX, in a concentration and time‐dependent manner when used alone and in combination with DTX. Notably, piperine also induced apoptosis and reduced the migration and invasion capabilities of these cells. At the molecular level, piperine down‐regulated the Notch pathway by inhibiting Notch1 and Jagged1 signaling, as well as reducing the expression of downstream effectors Hey1 and hes family bHLH transcription factor 1. The study concludes that piperine's ability to modulate the Notch signaling pathway and induce apoptosis highlights its potential as a complementary treatment for DTX‐resistant PCa, paving the way for the use of traditional Chinese medicinal compounds in modern oncology treatment strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polyunsaturated AlkamidesBenzodioxolesAlkaloidsPiperidinesDocetaxelSignal TransductionDrug Resistance, NeoplasmProstatic NeoplasmsApoptosisCell MovementHumansMaleCell Line, TumorReceptors, NotchAntineoplastic AgentsCell SurvivalReceptor, Notch1

Stichwörter der Autor:innen

Notch signaling pathwaychemoresistancedocetaxelpiperineprostate cancer

Substanzen

Polyunsaturated AlkamidespiperineBenzodioxolesAlkaloidsPiperidinesDocetaxelReceptors, NotchAntineoplastic AgentsReceptor, Notch1

Autor:innen und Institutionen

  • Department of Urology, Wujin Hospital Affiliated with Jiangsu University, Changzhou, China.
  • Department of Urology, The Wujin Clinical College of Xuzhou Medical University, Changzhou, China.

Zitieren

APA

Wang, R. T., Liu, H. E., & Sun, H. Y. (2024). In vitro modulation the Notch pathway by piperine: A therapeutic strategy for docetaxel‐resistant and non‐resistant prostate cancer. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.14562

Vancouver

Wang RT, Liu HE, Sun HY. In vitro modulation the Notch pathway by piperine: A therapeutic strategy for docetaxel‐resistant and non‐resistant prostate cancer. Chemical Biology & Drug Design. 2024. doi:10.1111/cbdd.14562

BibTeX
@article{Wang2024,
  author = {Wang, Rui-Tao and Liu, Hao-En and Sun, Hui-Yuan},
  title = {In vitro modulation the Notch pathway by piperine: A therapeutic strategy for docetaxel‐resistant and non‐resistant prostate cancer},
  journal = {Chemical Biology & Drug Design},
  year = {2024},
  doi = {10.1111/cbdd.14562}
}
Kostenlos starten →